The 4 most recent market catalysts affecting $INGN, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Nov 6, 2026
Corporate Catalyst
Neutral
Impact 85
Inogen Reports Q3 2026 Results, Appoints New CEO, and Announces Strategic Divestiture
Inogen's Q3 2026 results show a 2.4% year-over-year revenue decrease and a $14.8 million GAAP loss, indicating ongoing financial challenges. The appointment of a new CEO, Andy Redi…
Sep 30, 2026
Corporate Catalyst
Bullish
Impact 65
Inogen Agrees To Divest Its U.S. Oxygen Rental Operations To Rotech Healthcare For $25M
Inogen, a medical technology company, is divesting its U.S. oxygen rental operations to Rotech Healthcare for an estimated $25 million. This move is significant as it indicates Ino…
Aug 6, 2026
Corporate Catalyst
Bearish
Impact 75
Inogen Lowers FY2026 Sales Guidance from $366.000M-$373.000M to $355.000M-$361.000M vs $369.267M Est
Inogen (INGN) has lowered its FY2026 sales guidance from an initial range of $366.0 million-$373.0 million to a new range of $355.0 million-$361.0 million. This revised outlook is …
Aug 6, 2026
Corporate Catalyst
Bullish
Impact 92
Inogen Q2 Sales $95.084M Miss $95.233M Estimate
Inogen's Q2 sales of $95.084 million missed analyst consensus by a narrow margin of 0.16%. While the miss is small, any deviation from expectations, especially on the downside for …
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.